Skip to main content
John R. Stringham

John R. Stringham, MD

Languages spoken: English

Academic Information

Departments Adjunct - Surgery

Board Certification

  • American Board of Surgery
  • American Board of Thoracic Surgery (Thoracic Surg)

JOHN STRINGHAM, MD, is originally from Nashville, Tennessee. He earned his medical degree from Vanderbilt University School of Medicine. He completed a general surgery residency at the University of Colorado which included time working at the Trauma Research Center. He then completed a thoracic surgery fellowship at the University of Virginia in Charlottesville, VA. Dr. Stringham’s clinical interests include all aspects of benign and malignant pathology of the lung, mediastinum and esophagus. He has a specific interest in lung transplant surgery. He also has interest in disorders of the airway and chest wall including tumor resection and reconstruction. Research interests include technological innovations in thoracic surgery, and patient outcomes after thoracic surgery utilizing population-based data.

Education History

Undergraduate Vanderbilt University
BS
Clerkship Vanderbilt University School of Medicine
MD
Professional Medical Vanderbilt University School of Medicine
MD
Clerkship Vanderbilt University School of Medicine
MD
Internship University of Colorado School of Medicine
Intern
Residency University of Colorado School of Medicine
Resident
Research Fellow University of Colorado School of Medicine, Trauma Research Center
Research Fellow
Residency University of Colorado School of Medicine
Resident
Chief Resident University of Colorado School of Medicine
Chief Resident
Fellowship University of Virginia Health System
Fellow

Selected Publications

Journal Article

  1. Pannucci CJ, Fleming KI, Varghese TK Jr, Stringham J, Huang LC, Pickron TB, Prazak AM, Bertolaccini C, Momeni A (2020). Low anti-Factor Xa level predicts 90-day Symptomatic Venous Thromboembolism in Surgical Patients Receiving Enoxaparin Prophylaxis: A Pooled Analysis of Eight Clinical Trials. Ann Surg, 276(6), e682-e690.
  2. Stokes SM, Massarweh NN, Stringham JR, Varghese TK Jr (2019). Clinical-Pathologic Correlation and Guideline Concordance in Resectable Non-Small Cell Lung Cancer. Ann Thorac Surg, 108(3), 837-844.
  3. Pannucci CJ, Fleming KI, Bertolaccini C, Moulton L, Stringham J, Barnett S, Lin J, Varghese TK Jr (2020). Fixed or Weight-Tiered Enoxaparin After Thoracic Surgery for Venous Thromboembolism Prevention. Ann Thorac Surg, 109(6), 1713-1721.
  4. Stokes SM, Massarweh NN, Stringham JR, Varghese TK J (2020). Impact of Multimodality Treatment Sequence on Survival in Stage IIB Non-Small Cell Lung Cancer. The Annals of thoracic surgery,
  5. Cahill BC, Raman S, Stringham JR, McKellar SH, Selzman CH, Liou T (2019). Longer Life or More Life: Choose One Please. The Journal of surgical research, 237, 126-128.
  6. Nunns GR, Stringham JR, Gamboni F, Moore EE, Fragoso M, Stettler GR, Silliman CC, Banerjee (2018). Trauma and hemorrhagic shock activate molecular association of 5-lipoxygenase and 5-lipoxygenase-Activating protein in lung tissue. The Journal of surgical research, 229, 262-270.
  7. Stokes SM, Wakeam E, Swords DS, Stringham JR, Varghese TK J (2018). Impact of insurance status on receipt of definitive surgical therapy and posttreatment outcomes in early stage lung cancer. Surgery, 164(6), 1287-1293.